(Press-News.org) People who have obstructive sleep apnoea (OSA) may suffer worse symptoms if they live in areas with higher levels of air pollution, according to a multi-national study presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands [1].
Patients with OSA often snore loudly, their breathing starts and stops during the night, and they may wake up several times. Not only does this cause excessive sleepiness, but it can also increase the risk of high blood pressure, stroke, heart disease and type 2 diabetes. OSA is very common, but many people do not realise they have the condition.
The research was presented by Martino Pengo, Associate Professor from the University of Milano-Bicocca and clinician at Istituto Auxologico Italiano IRCCS, Milan, Italy. He told the Congress: “We know that OSA is more common in people who are older or overweight, but there’s growing concern that air pollution also might make the condition worse. However, previous studies, mostly focused on just one country, have produced mixed results. We wanted to look at this on a larger scale, across several European cities, to better understand if and how air pollution affects OSA.”
The study included data on 19,325 patients with OSA from 25 different cities in 14 countries [2]. All patients are taking part in a larger research project called the European Sleep Apnoea Database. As well as providing data on their age, sex, BMI and whether they smoke, all patients took part in a sleep study to measure the quality of their sleep and confirm a diagnosis of OSA, including recording pauses in breathing and drops in the level of oxygen in the blood.
Researchers combined this patient data with records of PM10 concentration in the air where each patient lives, taken from the Europe-wide Copernicus Atmosphere Monitoring Service. PM10 concentration is the amount of tiny particles, 10 micrometres or smaller, released into the air by vehicle exhausts and industrial processes, for example.
The analysis revealed that, overall, for every one unit increase in PM10, there was a modest but measurable increase in the patients’ apnoea hypopnea index (AHI). AHI is the number of apnoeas (when breathing stops) and hypopneas (when breathing is reduced) per hour during sleep. For example, among patients with low AHI (less than five) the average PM10 in the area where they live was relatively low (around 16 micrograms per cubic meter of air). In contrast, in patients with high AHI (five or more) the average PM10 was also higher (around 19 micrograms per cubic meter of air).
Researchers also found differences between the strength of the link between air pollution and OSA in different cities around Europe: for instance, in cities like Lisbon (Portugal), Paris (France), and Athens (Greece) the association was particularly strong.
Professor Pengo said: “We confirmed a statistically significant positive association between average long-term exposure to air pollution, specifically fine particles known as PM10, and the severity of obstructive sleep apnoea. Even after we took account for other factors that we know have an effect on OSA, we still found an average increase in the number of respiratory events per hour of sleep of 0.41 for every one unit increase in PM10. This effect may seem small for an individual, but across entire populations it can shift many people into higher-severity categories, making it meaningful from a public health perspective”.
“One of the most interesting findings was that the link between air pollution and OSA severity wasn’t the same in every European location. In some cities, the impact was stronger; in others, it was weaker or even absent. These regional differences might be due to things like local climate, the type of pollution or even how healthcare systems detect OSA.”
The researchers say they want to understand why the effects vary between cities and whether some people are more affected by pollution than others. They also hope to explore whether reducing pollution can improve sleep apnoea symptoms.
Professor Sophia Schiza is Head of the European Respiratory Society’s expert group on sleep disordered breathing, based at the University of Crete, Greece, and was not involved in the research. She said: “Obstructive sleep apnoea is a common condition. People who have OSA may know that they snore or wake up often in the night, and they may also feel sleepy during the day. There are also serious health risks associated with this condition. For people with OSA, especially those living in cities with high levels of air pollution, this study is important as it suggests pollution could be making their condition worse.
“For doctors caring for people with OSA, this research highlights the need to consider environmental factors like air quality alongside other risk factors. This study strengthens the connection between environmental health and sleep medicine. It reminds us that tackling air pollution isn't just good for the planet, it's also vital for our lungs and our sleep quality too.”
END
Higher levels of air pollution linked to worsening of sleep apnea
2025-09-28
ELSE PRESS RELEASES FROM THIS DATE:
ASTRO: New therapy delays progression of recurrent prostate cancer
2025-09-28
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease worsening compared with those who received SBRT alone, according to new clinical trial results from UCLA Health Jonsson Comprehensive Cancer Center researchers.
Findings from the trial, presented today at the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco, showed that men who received the radioligand drug ...
Low-dose radiation therapy offers substantial relief to people with painful knee osteoarthritis
2025-09-28
SAN FRANCISCO, September 28, 2025 — A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with painful knee osteoarthritis according to a new randomized, placebo-controlled clinical trial.
The study showed patients with mild to moderate knee osteoarthritis reported significant reductions in pain and improved physical function in the four months after receiving the low dose of radiation, which was just a small fraction of what’s used to treat cancer. Because the study included a control group with simulated treatment, the researchers could distinguish ...
Radiopharmaceutical added to stereotactic radiation delays prostate cancer progression in patients with limited metastatic disease
2025-09-28
SAN FRANCISCO, September 28, 2025 — A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a radiopharmaceutical drug before targeted radiation, compared with radiation alone.
The phase II LUNAR trial is the first randomized study to show that a treatment established for later-stage prostate cancer can delay progression and defer hormone therapy when added to high-precision radiation ...
First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer
2025-09-28
SAN FRANCISCO, September 28, 2025 — A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery — the first predictive biomarker in this setting.
In the first prospective, randomized trial to validate a predictive gene expression test for hormone therapy in prostate cancer, patients with a prostate tumor subtype known as luminal B had much lower risks of recurrence and metastasis when radiation was complemented by apalutamide, a type of hormone therapy. Patients without this tumor subtype, however, saw no improvement. ...
Specialised singing programmes can improve the symptoms and quality of life of people with lung disease
2025-09-28
Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomised-controlled trial presented at the European Respiratory Society Congress in Amsterdam, the Netherlands [1].
The study was presented by Professor Natasha Smallwood from Monash University, Melbourne, Australia.
Professor Smallwood told the Congress: “Chronic breathlessness is a common and highly distressing symptom for people with chronic obstructive pulmonary disease and interstitial lung disease. Yet there is a lack ...
Children with asthma who use at-home monitoring are half as likely to need hospital care
2025-09-28
Children with asthma who use at-home monitoring are around half as likely to visit the emergency department or be hospitalised, compared to those who only receive care from their medical team, according to research presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands [1]. Remote monitoring also helped keep children’s symptoms under control.
At-home monitoring involved children and their families using an app approximately once a month to answer questions ...
Combination inhaler reduces asthma attacks in children by almost half
2025-09-28
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.
In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be more effective than salbutamol, the current standard for asthma symptom relief in children, with no additional safety concerns.
The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – ...
Low-cost drug shows promise for patients with life threating respiratory infections
2025-09-28
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National University (ANU) in collaboration with King’s College London.
The study analysed data from almost 500 patients hospitalised with COVID-19 across six countries. Patients who inhaled heparin were half as likely to require ventilation and had a significantly lower risk of dying compared with those receiving standard care.
Heparin, a drug traditionally injected to treat blood clots, was tested in this study in an inhaled form, targeting the lungs directly. As well as acting as an anticoagulant, ...
Emergency medicine workers report job satisfaction, though burnout and staff retention remain major problems
2025-09-27
Vienna, Austria: One of the largest international surveys into job satisfaction among emergency department workers has revealed that while the majority found their work satisfying and rewarding, there are still many areas where improvements are needed, according to research presented at the European Emergency Medicine Congress today (Sunday) [1]. The paper, “Global Job Satisfaction Among Emergency Medicine Professionals: Results from the 2025 Emergency Medicine Day Survey”, is published today in the European Journal ...
Eating fruit may reduce the effects of air pollution on lung function
2025-09-27
Eating fruit may reduce the effects of air pollution on lung function
Eating fruit may reduce the effects of air pollution on lung function, according to research presented at the European Respiratory Society Congress in Amsterdam, the Netherlands [1].
The study was presented by Pimpika Kaewsri, a PhD student from the Centre for Environmental Health and Sustainability at the University of Leicester, UK.
She explains: “Over 90% of the global population is exposed to air pollution levels that exceed WHO guidelines, and ample ...